Germline mutations of BAP1 are associated with an autosomal dominant, novel cancer syndrome characterized by atypical Spitz tumors (AST), uveal melanoma, mesothelioma (MM), clear cell renal cell carcinoma, cutaneous melanoma (CM), and basal cell carcinoma (BCC) [9–13]. This evidence concerns the gene BAP1 and uveal melanoma.